Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients

Journal of Clinical Pharmacology

Volumn 42, Issue 6, 2002, Pages 644-650

  Muder, Robert R ^a   Agarwala, Sangeeta ^c   Mirani, Ajai ^c   Gayowski, Timothy ^b   Venkataramanan, Raman ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VA Healthcare VISN 4   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; CREATININE; SULBACTAM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE KIDNEY FUNCTION RELATION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG URINE LEVEL; GRAM NEGATIVE INFECTION; HUMAN; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; BILE; KIDNEY; METABOLIC CLEARANCE RATE; METABOLISM;

ADULT; ANTIBIOTICS, LACTAM; BILE; CEFOPERAZONE; HUMAN; KIDNEY; LIVER TRANSPLANTATION; METABOLIC CLEARANCE RATE; SULBACTAM; SUPPORT, NON-U.S. GOV'T; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0036000315     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00970002042006006     Document Type: Article

References (42)

1. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin
2. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria
3. Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections
4. Clinical experience with cefoperazone in biliary tract infection
5. Clinical pharmacokinetics of organ transplant patients
6. Biliary excretion of cyclosporine liver transplant patients
7. Excretion of cyclosporine and its metabolites in human bile
8. Pharmacokinetics of ceftriaxone in liver transplant recipients
9. Induction of CYP2El activity in liver transplant patients as measured by chlorzoxazone 6 hydroxylation
10. Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation
11. Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method
12. High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue
13. Single dose pharmacokinetics of cefoperazone following intravenous administration
14. Cefoperazone: Pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats
15. Cefoperazone: Absorption, excretion distribution and metabolism
16. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency
17. Pharmacokinetics of cefoperazone
18. A review and summary of the pharmacokinetics of cefoperazone: A new extended spectrum betalactam antibiotic
19. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function
20. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: Clinical and pathophysiological implications
21. Penetration of cefoperazone into surgical wound drainage in patients undergoing head and neck surgery
22. Pharmacokinetics and biliary excretion of cefoperazone in patients with bile duct drainage
23. Biliary excretion and pharmacokinetics of cefoperazone in humans
24. Cefoperazone concentrations in bile and gall bladder wall after intravenous administration
25. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime
26. Penetration of cefoperazone into ascites
27. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis
28. Multiple dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients
29. Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis
30. Multi-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination
31. Comparative Pharmacokinetics of cefoperazone and cefamandole
32. Comparative pharmacokinetics of cefoperazone and cefotaxime
33. Pharmacokinetics of cefoperazone in patients with neoplastic disease
34. Serum levels and urinary excretion of cefoperazone in patients with hepatic insufficiency
35. Serum, urine and bile levels of cefoperazone
36. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration
37. Pharmacokinetics of sulbactam in humans
38. The elimination of sulbactam and combined with ampicillin in patients with renal dysfunction
39. Pharmacokinetics of parenteral sulbactam in patients with appendicitis
40. Biliary pharmacokinetics of sulbactam plus ampicillin in humans
41. Pharmacokinetics of sulbactam/ampicillin in humans: A review